We present on our advanced #sequencing approaches towards #immunooncology treatment monitoring & their power in functional immune receptor discovery to create differentiated 'living drugs', at the Cambridge Healthtech Institute I-O Summit Europe on Mar 19. For more see: bit.ly/2TLPUYo

It is with great sadness that we learnt of the death of Professor Vincenzo Cerundolo FRS. Prof Cerundolo worked tirelessly and passionately for the benefit of our unit and the scientific community. He will be greatly missed. imm.ox.ac.uk/about/news/pro…

Some thoughts about the punctuated evolution of variants of concern including B.1.1.529 in Southern Africa. 🧵 A shared characteristic of all known VOCs is that they appeared suddenly with a large number of mutations, many more than the incremental changes we see normally.

It is with heavy hearts that we announce the passing of our beloved colleague and friend, C. David Allis. Aside from his groundbreaking contributions to biomedical science, David will be remembered for his warmth, humility, and relentless optimism.

$AGEN announces subsidiary AgenTus Therapeutics focused on advancing cell therapy for potential cures for cancer pts investor.agenusbio.com/2017-10-23-Age…